Dr. Greg Patey

Dr. Greg Patey has a comprehensive work experience. Dr. Greg founded Blue Charm Adherence Inc. in 2018 and served as the CEO. Prior to that, they were with STI Technologies Limited from 2002 to 2018, where they held various positions including Co-Founder and retired in July 2017. Before STI Technologies, they worked at Novo Nordisk as a management professional from 1999 to 2002, and at SmithKline Beecham Corporation in management roles from 1989 to 1999.

Dr. Greg Patey holds an Executive MBA from Saint Mary's University and a Doctor of Business Administration from the University of Liverpool. Their doctoral thesis focused on medication adherence in diseases requiring specialty medicines.